Skip to Main content Skip to Navigation
Journal articles

New amphiphilic and pH-sensitive hydrogel for controlled release of a model poorly water-soluble drug

Abstract : This paper presents the development of new pH-sensitive, amphiphilic and biocompatible hydrogels based on alginate-g-PCL, cross-linked with calcium ions to form beads, prepared for controlled delivery of poorly water-soluble drug. We have focused our study on the effect of the length of PCL chains (530 and 1250 g mol−1). Swelling profiles obtained clearly indicated that these hydrogels swell slightly (10–14%) in a simulated gastric fluid (pH 1.2), and strongly (700–1300% before disintegration) in a simulated intestinal fluid (pH 6.8). In both media, rates of swelling were lower for beads based on amphiphilic derivatives than for alginate/Ca2+ ones due to the hydrophobic PCL grafts, and decreased when hydrophobic character increased. A model drug, theophylline, was entrapped into these hydrogels and release studies were carried out. The drug was protected in acidic fluid (only 14–20% of release for alginate-g-PCL hydrogel against 35% of release for alginate hydrogel during 350 min). The drug is released completely in neutral fluid due to ion exchanges and disintegration of the hydrogel. PCL leads to decrease in the release kinetics in SIF (2 h for alginate-g-PCL/Ca2+ beads against 1 h for alginate/Ca2+ beads). It was demonstrated that the establishment of clusters inside beads by intramolecular interactions between PCL grafts of 530 g mol−1 in salt media allowed to retain the drug and to slow down its release considerably.
Document type :
Journal articles
Complete list of metadatas

https://hal-normandie-univ.archives-ouvertes.fr/hal-01866802
Contributor : Luc Picton <>
Submitted on : Monday, September 3, 2018 - 4:15:05 PM
Last modification on : Thursday, July 2, 2020 - 3:28:35 AM

Identifiers

Citation

I. Colinet, V. Dulong, G. Mocanu, L. Picton, D. Le Cerf. New amphiphilic and pH-sensitive hydrogel for controlled release of a model poorly water-soluble drug. European Journal of Pharmaceutics and Biopharmaceutics, Elsevier, 2009, 73 (3), pp.345 - 350. ⟨10.1016/j.ejpb.2009.07.008⟩. ⟨hal-01866802⟩

Share

Metrics

Record views

53